HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC.

Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a dismal disease with a poor clinical prognosis and unsatisfactory treatment options. We previously found that the transcription factor CCAAT/Enhancer-Binding Protein Delta (C/EBPδ) is lowly expressed in PDAC compared to healthy pancreas duct cells, and that patient survival and lymph node involvement in PDAC is correlated with the expression of C/EBPδ in primary tumor cells. C/EBPδ shares a homologous DNA-binding sequence with other C/EBP-proteins, leading to the presumption that other C/EBP-family members might act redundantly and compensate for the loss of C/EBPδ. This implies that patient stratification could be improved when expression levels of multiple C/EBP-family members are considered simultaneously. In this study, we assessed whether the quantification of C/EBPβ or C/EBPγ in addition to that of C/EBPδ might improve the prediction of patient survival and lymph node involvement using a cohort of 68 resectable PDAC patients. Using Kaplan-Meier analyses of patient groups with different C/EBP-expression levels, we found that both C/EBPβ and C/EBPγ can partially compensate for low C/EBPδ and improve patient survival. Further, we uncovered C/EBPβ as a novel predictor of a decreased likelihood of lymph node involvement in PDAC, and found that C/EBPβ and C/EBPδ can compensate for the lack of each other in order to reduce the risk of lymph node involvement. C/EBPγ, on the other hand, appears to promote lymph node involvement in the absence of C/EBPδ. Altogether, our results show that the redundancy of C/EBP-family members might have a profound influence on clinical prognoses and that the expression of both C/EPBβ and C/EBPγ should be taken into account when dichotomizing patients according to C/EBPδ expression.
AuthorsLeonie Hartl, Joris J T H Roelofs, Frederike Dijk, Maarten F Bijlsma, JanWillem Duitman, C Arnold Spek
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 24 Issue 2 (Jan 12 2023) ISSN: 1422-0067 [Electronic] Switzerland
PMID36675048 (Publication Type: Journal Article)
Chemical References
  • CCAAT-Enhancer-Binding Protein-beta
  • CCAAT-Enhancer-Binding Protein-delta
  • CCAAT-Enhancer-Binding Proteins
  • CEBPD protein, human
  • CCAAT-enhancer-binding protein-gamma
  • CEBPB protein, human
Topics
  • Humans
  • CCAAT-Enhancer-Binding Protein-beta (genetics, metabolism)
  • CCAAT-Enhancer-Binding Protein-delta (genetics, metabolism)
  • CCAAT-Enhancer-Binding Proteins (genetics, metabolism)
  • Gene Expression Regulation (genetics, physiology)
  • Lymph Nodes (metabolism, pathology)
  • Pancreatic Neoplasms (genetics, metabolism, pathology)
  • Carcinoma, Pancreatic Ductal (genetics, metabolism, pathology)
  • Lymphatic Metastasis (genetics, pathology, physiopathology)
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: